These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8262339)

  • 21. FDA new drug approvals in 2005.
    Wynn RL
    Gen Dent; 2006; 54(4):230-3. PubMed ID: 16903192
    [No Abstract]   [Full Text] [Related]  

  • 22. FDA new drug approvals in 2007.
    Wynn RL
    Gen Dent; 2008; 56(6):506-10. PubMed ID: 18810906
    [No Abstract]   [Full Text] [Related]  

  • 23. FDA new drug approvals in 2006.
    Wynn RL
    Gen Dent; 2007; 55(4):275-9. PubMed ID: 17682633
    [No Abstract]   [Full Text] [Related]  

  • 24. FDA new drug approvals in 2004.
    Wynn RL
    Gen Dent; 2005; 53(4):246-8. PubMed ID: 16158789
    [No Abstract]   [Full Text] [Related]  

  • 25. US FDA approves Emtriva (FTC).
    IAPAC Mon; 2003 Aug; 9(8):180. PubMed ID: 14669738
    [No Abstract]   [Full Text] [Related]  

  • 26. Will FDA relinquish the "gold standard" for new drug approval? Redefining "substantial evidence" in the FDA Modernization Act of 1997.
    Kulynych J
    Food Drug Law J; 1999; 54(1):127-49. PubMed ID: 11758555
    [No Abstract]   [Full Text] [Related]  

  • 27. Significant FDA approvals in 1994.
    Rheinstein PH
    Am Fam Physician; 1995 Mar; 51(4):888-90. PubMed ID: 7887364
    [No Abstract]   [Full Text] [Related]  

  • 28. Significant FDA approvals in 2000.
    McGinnis TJ
    Am Fam Physician; 2001 May; 63(10):2061-4. PubMed ID: 11388719
    [No Abstract]   [Full Text] [Related]  

  • 29. Between a rock and a hard place.
    Demaria AN
    J Am Coll Cardiol; 2010 Nov; 56(21):1761-2. PubMed ID: 21070930
    [No Abstract]   [Full Text] [Related]  

  • 30. FDA: friend or foe?
    Lewis TS
    Med Device Technol; 1996 Nov; 7(9):24-30. PubMed ID: 10163675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significant FDA approvals in 1996.
    Rheinstein PH
    Am Fam Physician; 1997 Jun; 55(8):2855-8. PubMed ID: 9191461
    [No Abstract]   [Full Text] [Related]  

  • 32. FDA-VMAC calls for increased regulation of new antimicrobials; animal groups question conclusion.
    Nolen S
    J Am Vet Med Assoc; 1999 Mar; 214(6):767, 772. PubMed ID: 10101403
    [No Abstract]   [Full Text] [Related]  

  • 33. FDA notifications. FDA approves raltegravir for HIV-1 treatment-naive patients.
    AIDS Alert; 2009 Sep; 24(9):106-7. PubMed ID: 19938313
    [No Abstract]   [Full Text] [Related]  

  • 34. FDA prohibits extralabel use of two drug classes.
    J Am Vet Med Assoc; 1997 Aug; 211(3):269. PubMed ID: 9262656
    [No Abstract]   [Full Text] [Related]  

  • 35. FDA says 'Look at the facts' when judging its record on drug approvals.
    Gatty B
    Formulary; 1995 Jul; 30(7):412, 411. PubMed ID: 10151732
    [No Abstract]   [Full Text] [Related]  

  • 36. FDA reform in Congress: interview with Peter Barton Hutt. Food and Drug Administration. Interview by John S. James.
    Hutt PB
    AIDS Treat News; 1996 Apr; (no 245):4-5. PubMed ID: 11363623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significant FDA approvals in 2001.
    McGinnis TJ
    Am Fam Physician; 2002 Jun; 65(11):2377-8, 2380, 2383. PubMed ID: 12074535
    [No Abstract]   [Full Text] [Related]  

  • 38. FDA notifications. FDA grants tentative approval to generic Nevirapine.
    AIDS Alert; 2006 Feb; 21(2):23-4. PubMed ID: 16562340
    [No Abstract]   [Full Text] [Related]  

  • 39. FDA notifications. FDA grants tentative approval to generic stavudine.
    AIDS Alert; 2006 Feb; 21(2):24. PubMed ID: 16562341
    [No Abstract]   [Full Text] [Related]  

  • 40. Sanofi Pharmaceuticals, Inc., et al.; withdrawal of approval of 21 new drug applications and 62 abbreviated new drug applications--FDA. Notice.
    Fed Regist; 1998 May; 63(91):26191-3. PubMed ID: 10179336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.